Rituximab for thyroid-associated ophthalmopathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rituximab for thyroid-associated ophthalmopathy

Published:2022-06-16 Issue:6 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Kang Swan¹,Hamed Azzam Shirin¹,Minakaran Neda²,Ezra Daniel G³

Affiliation:

1. Moorfields Eye Hospital NHS Foundation Trust; London UK

2. Department of Ophthalmology; Moorfields Eye Hospital NHS Foundation Trust; London UK

3. Moorfields and UCL Institute of Ophthalmology BMRC; Moorfields Eye Hospital NHS Foundation Trust; London UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference82 articles.

1. Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study;Salvi;Journal of Clinical Endocrinology and Metabolism

2. Randomized controlled trial of rituximab in patients with Graves' orbitopathy;Stan;Journal of Clinical Endocrinology and Metabolism,2015

3. B lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: a controlled pilot study;El Fassi;Journal of Clinical Endocrinology and Metabolism,2007

4. Treatment-resistant severe, active Graves' ophthalmopathy successfully treated with B lymphocyte depletion;El Fassi;Thyroid,2006

5. Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' disease;El Fassi;Gut,2008

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multifactorial screening model based on the Graves ophthalmopathy quality of life scores in dysthyroid optic neuropathy;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-06-24

2. An observation study of the effect of “Internet + Nursing” on psychological status and quality of life of patients with thyroid eye disease;Medicine;2024-04-26

3. The changing landscape of thyroid eye disease: current clinical advances and future outlook;Eye;2024-02-19

4. Reduction in Extraocular Muscle Cross-sectional Area and Correlation With Extraocular Motility and Diplopia Following Teprotumumab for Thyroid Eye Disease;Ophthalmic Plastic & Reconstructive Surgery;2023-02-28

5. Rituximab for Ocular Inflammatory Disease;Ocular Immunology and Inflammation;2022-08-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3